| Net Cash Provided by (Used in) Operating Activities |
-289K |
USD |
+25.6% |
Q2 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
141K |
USD |
-39.7% |
Q2 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
140K |
USD |
-57.6% |
Q2 2024 |
Q1 2025 |
| Common Stock, Shares Authorized |
1.85B |
shares |
+640% |
Q4 2024 |
Q3 2025 |
| Common Stock, Shares, Issued |
99.1M |
shares |
+75.9% |
Q4 2024 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q4 2024 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-8.58K |
USD |
-105% |
Q2 2024 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
9.56K |
USD |
-76.1% |
Q3 2024 |
Q2 2025 |
| Deferred Tax Assets, Valuation Allowance |
1.02M |
USD |
+8.63% |
Q1 2024 |
FY 2024 |
| Depreciation |
15.5K |
USD |
|
Q4 2023 |
Q3 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-1.68M |
USD |
-119% |
Q1 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
1.02M |
USD |
+8.63% |
Q1 2024 |
FY 2024 |
| Additional Paid in Capital |
17.5M |
USD |
+666% |
Q4 2024 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
96.6K |
USD |
-34.1% |
Q1 2023 |
FY 2023 |
| Share-based Payment Arrangement, Expense |
250K |
USD |
|
Q4 2023 |
Q3 2024 |
| Interest Expense |
8.15K |
USD |
-1.35% |
Q3 2023 |
Q2 2024 |